Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension

scientific article published on 01 January 1991

Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-8703(91)90862-C
P953full work available at URLhttps://api.elsevier.com/content/article/PII:000287039190862C?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:000287039190862C?httpAccept=text/xml
P698PubMed publication ID1824653

P2093author name stringF. Wessels
P2860cites workAcute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exerciseQ34446820
A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertensionQ34446826
The antihypertensive effects of doxazosin: a clinical overviewQ34446834
Clinical pharmacological studies with doxazosinQ34446840
Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteinsQ34446855
Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertensionQ34446862
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failureQ39501948
Changing perspectives in the prevention of coronary artery diseaseQ39589337
Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertensionQ41761965
Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertensionQ42127517
Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonistQ42664441
A pharmacodynamic and pharmacokinetic assessment of a new alpha- adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjectsQ43241370
Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study.Q52493872
Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertensionQ70058875
Doxazosin in patients with hypertensionQ70068419
P433issue1 Pt 2
P407language of work or nameEnglishQ1860
P921main subjectenalaprilQ422185
essential hypertensionQ988405
Cardiology and cardiovascular medicineQ96320350
P304page(s)299-303
P577publication date1991-01-01
P1433published inAmerican Heart JournalQ2227156
P1476titleDouble-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension
P478volume121